Showing results (1061-1070 of 4,874) with videos related to

Sort By:
Pageof 488
Urologic Oncology|February 4, 2024
Germline variants in early and late-onset Brazilian prostate cancer patientsKaroline Brito Caetano Andrade Coelho, Jeremy A Squire, Kelly Gomes Duarte, et al.
Urologic Oncology|January 20, 2024
Magnetic resonance imaging-ultrasound fusion guided focal cryoablation for men with intermediate-risk prostate cancerAbhinav Sidana, Shima Tayebi, Fernando Blank, et al.
Urologic Oncology|January 21, 2024
Maximizing efficiency and ensuring safety: Exploring the outcomes of 2 consecutive open radical cystectomies by the same team within a single surgical dayLuisa Egen, Frederik Wessels, Allison Quan, et al.
Urologic Oncology|August 27, 2024
Lymph node density as a prognostic marker of relapse in patients who underwent primary retroperitoneal lymph node dissectionJulian Chavarriaga, Ahmad Mousa, Eshetu G Atenafu, et al.
Urologic Oncology|September 29, 2024
Navigating the gray zone: Machine learning can differentiate malignancy in PI-RADS 3 lesionsEmre Altıntaş, Ali Şahin, Seyit Erol, et al.
Urologic Oncology|September 18, 2024
Impact of heavy metals, oxidative stress, expression of VHL, and antioxidant genes in the pathogenesis of renal cell carcinomaKevin Arulraj, Javed Ahsan Quadri, Brusabhanu Nayak, et al.
Urologic Oncology|September 11, 2024
Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levelsChristian D Fankhauser, Marian S Wettstein, Ailsa J Christiansen, et al.
Urologic Oncology|October 5, 2024
Differences in the treatment patterns of small renal masses: A disaggregated analyses by race/ethnicitySamuel Carbunaru, Jordan M Rich, Yassamin Neshatvar, et al.
Urologic Oncology|October 18, 2024
Robotic partial nephrectomy: Indications, patient selection, and setup for successPatrick Etta, Michael Chien, Yuzhi Wang, et al.
Urologic Oncology|October 10, 2024
Clinical significance of PSA dynamics in castration-sensitive prostate cancer treated with ARSI doublet therapy: A multicenter studyFumihiko Urabe, Shingo Hatakeyama, Takafumi Yanagisawa, et al.
Pageof 488